Anchala AR, Pasquale LR. Neovascular Glaucoma. A historical perspective on modulating angiogenesis. Semin Ophthalmol 2009;24:106-112.
Hayreh SS. Neovascular Glaucoma. Prog Ret Eye Res 2007;26:470-485
Kubota, Toshiaki; Tawara, Akihiko; Hata, Yasuaki; Khalil, Ahmad; Inomata, Hajime. Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma. Br J Ophthalmol. 1996 August; 80(8): 750-754.
Tasman W, Magargal LE, Augsburger JJ. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 1980;87:400.
Brown GC, Magargal LE, Schachat A, Shah J. Neovascular Glaucoma. Etiologic considerations. Ophthalmology 1984;91:315-320.
Glaucomas associated with disorders of the retina, vitreous and choroids. In: Allingham RA, Damji KF, Freedman S, et al, eds. Shields' Textbook of Glaucoma. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005:328-346.
Adamis AP, Miller JW, O'Reilly M, et al. Vascular permeability factor (vascular endothelial growth factor) is produced in the retina and elevated levels are present in the aqueous humor of eyes with iris neovascularization. Invest Ophthalmol Vis Sci 1993;34:1440 ARVO Abstract.
Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Eng J Med 1994;331:1480-1487.
Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445-450.
Yong Guk Kim, Samin Hong, Christopher Seungkyu Lee, Sung Yong Kang, Gong Je Seong, Kyoung Tak Ma, Chan Yun Kim. Level of Vascular Endothelial Growth Factor in Aqueous Humor and Surgical Results of Ahmed Glaucoma Valve Implantation in Patients With Neovascular Glaucoma. J Glaucoma 2009;18:443-447
Sinclair SH, Aaberg TM, Meredith TA. A pars plana filtering procedure combined with lensectomy and vitrectomy for neovascular glaucoma. Am J Ophthalmol 1982;93:185-191
Lloyd MA, Heuer DK, Baerveldt G, et al. Combined Molteno implantation and pars plana vitrectomy for neovascular glaucoma. Ophthalmology 1991;98:1401-1405.
Gandham SB, Costa VP, Katz LJ, et al. Aqueous tube-shunt implantation and pars plana vitrectomy in eyes with refractory glaucoma. Am J Ophthalmol 1993;116:189-195
Luttrull JK, Avery RL. Pars plana implant and vitrectomy for treatment of neovascular glaucoma. Retina 1995;15:379-387
Faghihi H, Hajizadeh F, Mohammadi SF, et al. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2007;38:292-300
Bartz-Schmidt K, Thumann G, Psichias A, et al. Pars plana vitrectomy, endolaser coagulation of the retina and ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 1999;237:969-975.
Kiuchi Y, Nakae K, Saito Y, et al. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 2006;244:1627-1632.
Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) for the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695-1705.
Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008;115:1571-1580.
Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006;26:354-356.
Beutel J, Peters S, Luke M, et al. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmologica 2008:1-7.
Torres-Soriano M, Reyna-Castelan E, Hernandez Rojas M, et al. Tractional retinal detachment after intravitreal injection of bevacizumab in proliferative diabetic retinopathy. Retin Cases Brief Rep 2009;3:70-73
Arevalo JF, Maia M, Flynn HW Jr, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:213-216.
Tranos P, Gemenetzi M, Papandroudis A, et al. Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin. Eye 2008;22:862.
Jonas JB, Schmidbauer M, Rensch F. Progression of tractional retinal detachment following intravitreal bevacizumab. Acta Ophthalmol 2009;87:571-572.
Blanc JP, Molteno AC, Fuller JR, Bevin TH, Herbison P. Life expectancy of patients with neovascular glaucoma drained by Molteno implants. Clin Experiment Ophthalmol. 2004 Aug;32(4):360-3.
